Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1B | P49286 | 11/20 | 0.54 |
| ▸ | MTNR1A | P48039 | 10/20 | 0.54 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.43 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8098235 | 1.00 | MTNR1B (0.54) | MTNR1BMTNR1ASLC5A1SLC5A2SLC6A2 | |
| SCHEMBL8095379 | 0.86 | MTNR1B (0.52) | MTNR1BMTNR1ASLC6A2SLC6A4 | |
| SCHEMBL8098503 | 0.86 | MTNR1B (0.52) | MTNR1BMTNR1ASLC6A2SLC6A4 | |
| SCHEMBL8095382 | 0.86 | MTNR1B (0.52) | MTNR1BMTNR1ASLC6A2SLC6A4 | |
| SCHEMBL8098501 | 0.86 | MTNR1B (0.52) | MTNR1BMTNR1ASLC6A2SLC6A4 | |
| SCHEMBL8088845 | 0.85 | MTNR1B (0.51) | MTNR1BMTNR1ASLC6A2SLC6A4 | |
| SCHEMBL8098179 | 0.85 | MTNR1B (0.51) | MTNR1BMTNR1ASLC6A2SLC6A4L3MBTL1 | |
| SCHEMBL8098175 | 0.85 | MTNR1B (0.51) | MTNR1BMTNR1ASLC6A2SLC6A4L3MBTL1 | |
| SCHEMBL8096202 | 0.85 | HTR2C (0.51) | MTNR1BMTNR1ASLC6A2SLC6A4 | |
| SCHEMBL8096201 | 0.85 | HTR2C (0.51) | MTNR1BMTNR1ASLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0747346-B1 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL MYERS SQUIBB CO (US) | 2000-02-16 | — | — | EP | claimed |